Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3057% below fair value
$58.11−1.30 (-2.19%)
Close on Nov 18, 2026Market cap $1.68BP/E 12.6Yield –
Inspire Medical Systems operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Inspire Medical Systems's operating income for the twelve months ending Jun 30, 2026 was $54.12M, up 30.7% year over year. For fiscal 2025 it was $50.95M, up 41.2% from the year before. The highest annual figure on record is $50.95M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.95M | +41.2% |
| FY2024 | Dec 31, 2024 | $36.08M | – |
| FY2023 | Dec 31, 2023 | -$40.27M | – |
| FY2022 | Dec 31, 2022 | -$47.59M | – |
| FY2021 | Dec 31, 2021 | -$39.85M | – |
| FY2020 | Dec 31, 2020 | -$56.21M | – |
| FY2019 | Dec 31, 2019 | -$34.90M | – |
| FY2018 | Dec 31, 2018 | -$20.38M | – |
| FY2017 | Dec 31, 2017 | -$16.00M | – |
| FY2016 | Dec 31, 2016 | -$17.25M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$514.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.12M | – |
| Q4 FY2025 | Dec 31, 2025 | $46.11M | +44.6% |
| Q3 FY2025 | Sep 30, 2025 | $9.64M | -32.6% |
| Q2 FY2025 | Jun 30, 2025 | -$3.32M | -165.0% |
| Q1 FY2025 | Mar 31, 2025 | -$1.49M | – |
| Q4 FY2024 | Dec 31, 2024 | $31.88M | +242.9% |
| Q3 FY2024 | Sep 30, 2024 | $14.32M | – |
| Q2 FY2024 | Jun 30, 2024 | $5.10M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.22M | – |
| Q4 FY2023 | Dec 31, 2023 | $9.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.47M | – |
| Q2 FY2023 | Jun 30, 2023 | -$16.60M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.50M | – |
| Q4 FY2022 | Dec 31, 2022 | -$335.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.19M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.06M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.82M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.54M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.89M | – |
| Q2 FY2020 | Jun 30, 2020 | -$22.81M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.44M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.29M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.90M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.65M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.64M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.85M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.65M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.38M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.12M | – |
See a number that looks wrong?